In murine models (Figure 8A), while curcumin, anti-PD-L1, or anti-CTLA4 monotherapy significantly reduced tumor growth rates, combination treatments further decreased tumor growth rates, volumes, and weights (Figure 8B-D). Here, CTLA4 is linked to neoplasm.